[CITATION][C] Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides
RS Geary, JM Leeds, SP Henry… - Anti-cancer drug …, 1997 - pubmed.ncbi.nlm.nih.gov
Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic
properties of phosphorothioate oligodeoxynucleotides Antisense oligonucleotide inhibitors
for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate
oligodeoxynucleotides Anticancer Drug Des. 1997 Jul;12(5):383-93. Authors RS Geary 1 ,
JM Leeds, SP Henry, DK Monteith, AA Levin Affiliation 1 Isis Pharmaceuticals, Inc., Carlsbad,
CA 92008, USA. rgeary@isisph.com PMID: 9236854 No abstract available Publication …
properties of phosphorothioate oligodeoxynucleotides Antisense oligonucleotide inhibitors
for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate
oligodeoxynucleotides Anticancer Drug Des. 1997 Jul;12(5):383-93. Authors RS Geary 1 ,
JM Leeds, SP Henry, DK Monteith, AA Levin Affiliation 1 Isis Pharmaceuticals, Inc., Carlsbad,
CA 92008, USA. rgeary@isisph.com PMID: 9236854 No abstract available Publication …